Enviar artigo por via de e-mail Studying of the Mechanisms of Combined Effect of Dexamethasone, Doxorubicin, and Docetaxel on Breast Cancer Cells
- Autores: Dukhanina E.A.1, Portseva T.N.1,2, Dukhanin A.S.2, Georgieva S.G.1
-
Afiliações:
- V. A. Engelhard Institute of Molecular Biology, Russian Academy of Sciences
- N. I. Pirogov Russian National Research Medical University, Ministry of Health of the Russian Federation
- Edição: Volume 166, Nº 1 (2018)
- Páginas: 54-57
- Seção: Article
- URL: https://journals.rcsi.science/0007-4888/article/view/240828
- DOI: https://doi.org/10.1007/s10517-018-4288-2
- ID: 240828
Citar
Acesso aberto
Acesso está concedido
Somente assinantes
Resumo
The sensitivity of MDA-MB231 breast cancer cells to the effects of pharmacological agents was evaluated by their motility and viability. Dexamethasone, doxorubicin, or docetaxel administered separately in their effective concentration suppressed cell motility (in 16 h) and caused cell death (in 48 h). The strength of the effects increased in the following order: dexa methasone
Sobre autores
E. Dukhanina
V. A. Engelhard Institute of Molecular Biology, Russian Academy of Sciences
Autor responsável pela correspondência
Email: das03@rambler.ru
Rússia, Moscow
T. Portseva
V. A. Engelhard Institute of Molecular Biology, Russian Academy of Sciences; N. I. Pirogov Russian National Research Medical University, Ministry of Health of the Russian Federation
Email: das03@rambler.ru
Rússia, Moscow; Moscow
A. Dukhanin
N. I. Pirogov Russian National Research Medical University, Ministry of Health of the Russian Federation
Email: das03@rambler.ru
Rússia, Moscow
S. Georgieva
V. A. Engelhard Institute of Molecular Biology, Russian Academy of Sciences
Email: das03@rambler.ru
Rússia, Moscow
Arquivos suplementares
